OncoMed Pharmaceuticals, Inc. Operating Income 2013-2018 | OMED
OncoMed Pharmaceuticals, Inc. operating income from 2013 to 2018. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| OncoMed Pharmaceuticals, Inc. Annual Operating Income (Millions of US $) |
|
|---|---|
| 2018 | $-10 |
| 2017 | $-41 |
| 2016 | $-103 |
| 2015 | $-86 |
| 2014 | $-51 |
| 2013 | $-24 |
| 2012 | $-22 |
| 2011 | $-15 |
| 2010 | $-29 |
| OncoMed Pharmaceuticals, Inc. Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2018-12-31 | $-5 |
| 2018-09-30 | $6 |
| 2018-06-30 | $-5 |
| 2018-03-31 | $-6 |
| 2017-12-31 | $8 |
| 2017-09-30 | $-11 |
| 2017-06-30 | $-15 |
| 2017-03-31 | $-23 |
| 2016-12-31 | $-22 |
| 2016-09-30 | $-26 |
| 2016-06-30 | $-28 |
| 2016-03-31 | $-27 |
| 2015-12-31 | $-25 |
| 2015-09-30 | $-25 |
| 2015-06-30 | $-22 |
| 2015-03-31 | $-15 |
| 2014-12-31 | $-16 |
| 2014-09-30 | $-6 |
| 2014-06-30 | $-16 |
| 2014-03-31 | $-14 |
| 2013-12-31 | $-2 |
| 2013-09-30 | $-3 |
| 2013-06-30 | $-9 |
| 2013-03-31 | $-9 |
| 2012-09-30 | $-4 |
| 2012-06-30 | $-4 |
